Biotechnology Reagents Market Poised to Surge from USD 56.4 Billion in 2015 to USD 94.6 Billion, Globally by 2021 – ZionMarketResearch.Com

//
Categories
Sarasota, FL, Aug. 22, 2016 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Biotechnology Reagents Market by Technology (Chromatography, Electrophoresis, PCR, Mass Spectrometry, Flow Cytometry, Tissue Culture, Expression and Transfection) for DNA & RNA Analysis, Protein Purification, Drug Testing, and Gene Expression, by End-user (Biotech Companies, Pharmaceuticals, Research Institutes, Diagnostic Centers and...
Read More →

Osteoporosis Therapeutics in Asia-Pacific (APAC) Markets to 2022: Industry Size, Shares, Trends, Opportunities, Survey and Forecast: ResearchMoz

Albany, NY, Aug. 22, 2016 (GLOBE NEWSWIRE) — Osteoporosis, the most common metabolic bone disease, is characterized by low bone mass, microarchitectural deterioration of bone tissue, and a consequent increase in fracture risk. Osteoporosis is generally known as an asymptomatic disease, as there are no visible signs until a fracture occur. In most of the...
Read More →

Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.’s holding in Metso

Helsinki, Finland, Aug. 22, 2016 (GLOBE NEWSWIRE) — Metso Corporation has received a notification, pursuant to Chapter 9, Section 5 and 6 of the Finnish Securities Markets Act, about a change in the holding of mutual funds managed by BlackRock, Inc. of the total amount of shares and financial instruments entitling to shares of Metso...
Read More →

Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.'s holding in Metso

Helsinki, Finland, Aug. 22, 2016 (GLOBE NEWSWIRE) — Metso Corporation has received a notification, pursuant to Chapter 9, Section 5 and 6 of the Finnish Securities Markets Act, about a change in the holding of mutual funds managed by BlackRock, Inc. of the total amount of shares and financial instruments entitling to shares of Metso...
Read More →

Góð afkoma OR á fyrri hluta ársins

//
Categories
Reykjavík, 2016-08-22 18:32 CEST (GLOBE NEWSWIRE) — Afkoma Orkuveitu Reykjavíkur (OR) er stöðug og góð. Á fyrri helmingi ársins 2016 skilaði reksturinn 5,0 milljarða króna hagnaði. Á sama tímabili 2015 var 2,3 milljarða króna hagnaður. Viðvarandi sparnaður í rekstri og hagstæð gengisþróun eiga þátt í bættri afkomu. Launakostnaður hefur hækkað í samræmi við nýlega kjarasamninga....
Read More →